They Said It

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS

May 12, 2023

Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On Read More

THEY SAID IT! LAWMAKERS SLAM MODERNA FOR EGREGIOUS COVID-19 VACCINE PRICE HIKE

Mar 23, 2023

Senate HELP Committee Members Slam Moderna’s CEO for Instituting Nearly 500 Read More

THEY SAID IT! SENATORS HIGHLIGHT URGENCY TO HOLD BIG PHARMA ACCOUNTABLE TO LOWER DRUG PRICES

Feb 13, 2023

Senate Judiciary Committee Advances Bipartisan Legislation Cracking Down on Read More

THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK

Jun 16, 2022

Federal Trade Commission Workshop Highlights How Brand Name Drug Companies Read More

THEY SAID IT! FINANCE COMMITTEE HIGHLIGHTS URGENCY TO HOLD BIG PHARMA ACCOUNTABLE FOR PRICE HIKES AND ANTI-COMPETITIVE BEHAVIOR

Mar 17, 2022

Lawmakers Double-Down on Repeated Promises to the American People to Lower Read More

WHAT THEY ARE SAYING: AMERICANS NATIONWIDE CALL ON CONGRESS TO LOWER RX PRICES NOW

Oct 21, 2021

Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented Read More

THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES

Jul 14, 2021

Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control Read More

WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS

Jun 14, 2021

Broad-based Opposition to Egregious Launch Price on Drug With Unproven Read More

THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS

May 5, 2021

Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver Read More